Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
A switch to a regimen consisting of ATV/RTV 300/100 mg QD + 3TC 300 mg QD in HIV-1 infected subjects in their first antiretroviral regimen and who are virologically suppressed on a regimen which consists of 2 NRTIs + any 3rd agent, is non-inferior to continue or switch to ATV/RTV 300/100 mg QD + 2 optimized NRTIs for maintenance of virological suppression.
Epistemonikos ID: 27374747c4234ddc923a82bcc3194573ca3d565d
First added on: Oct 10, 2019